Current Study Opportunities at The CRC
Studies at CRC can change frequently. For the most up to date information of current enrolling studies please fill out the form on the right or call 314-514-8509 ext 12 to see if you qualify for a study. Studies listed were updated on 1-12-22.
Study #1: An investigational research study of an inhaled triple therapy versus Symbicort for people with moderate to severe asthma.
Brief description of study
This investigational research study has 15 visits. Subjects must be currently using medium to high daily dose inhaled maintenance medication. This study does have a BMI (Body Mass Index) restriction of less than 40. Must be 12-80 years of age and non-smoker with little to no previous smoke history.
Compensation for participation may be provided for those who qualify. Please fill out the Volunteer Questionnaire or call 314-514-8509
Study #2: COPD Research Study comparing investigational inhaled triple therapy to investigational inhaled double therapy.
Brief description of study
This study requires 12 visits over approximately 55 weeks. A chest x-ray is required within 6 months of or at screening. Subjects must be at least 40 years of age with physician diagnosed COPD and be treating with a daily inhaled maintenance therapy with a stable dose for at least 3 months. Subjects must have experienced a COPD flare requiring treatment with oral steroids or antibiotics or have been hospitalized within the past 12 months.
Compensation for participation may be provided for those who qualify. Please fill out the Volunteer Questionnaire or call 314-514-8509
Study #3: Research Study of an investigational oral medication taken twice daily for adults with diagnosed Refractory Chronic Cough including Unexplained Chronic Cough
Brief description of study
This research study requires 20 visits over approximately 72 weeks. Subjects must have persistent cough for at least one year and a diagnosis of Chronic Refractory Cough with insufficient improvement after treatment for underlying conditions or for which no underlying conditions have been determined despite adequate investigation with diagnostic tests and trials of therapy. Subjects are required to wear a 24-hour cough monitor multiple times over the 52 weeks.
Compensation for participation may be provided for those who qualify. Please fill out the Volunteer Questionnaire or call 314-514-8509
Study #4: Research study for Chronic Spontaneous Urticaria (Hives) testing the efficacy and safety of an investigational daily oral medication versus placebo
Brief description of study
This research study requires 12 visits over approximately 48 weeks. Subjects must be between 18-65 years of age and have been diagnosed with chronic spontaneous hives for at least the past 3 months. Hives must be inadequately controlled despite treatment with second-generation H-1 antihistamines (for example: Claritin, Allegra, Zyrtec, etc.). Subjects cannot be on current treatment with biologics (for example: omalizumab, dupilumab, etc.) or have a clearly defined predominant or sole trigger for their hives. After the first 12 weeks of treatment, there is an open-label extended period of treatment for 24 weeks where all participants are assigned one of three doses of the investigational drug.
Compensation for participation may be provided for those who qualify. Please fill out the Volunteer Questionnaire or call 314-514-8509
Study #5: Asthma Research Study for persons with Asthma, ages 12-80, treating with low-dose maintenance medication for at least 8 weeks
Brief description of study
This study requires 7 visits over approximately 15 weeks. Morning appointments required. Subjects must have asthma for at least 6 months and currently treating with low-dose inhaled steroids (ICS or ICS/LABA, for example, Symbicort, Pulmicort, Advair, Flovent, etc.) for at least 8 weeks. Patients must be 12-80 years of age, non-smoker and BMI (Body Mass Index) of less than 40.
Compensation for participation may be provided to those who qualify. Please fill out the Volunteer Questionnaire or call 314-514-8509 for more details.
Study #6: Investigational Asthma study comparing an approved combination inhaler versus an investigational combination inhaler.
Brief description of study
This study requires 8 visits over approximately 24 weeks. Morning appointments required. Subjects must have asthma for at least 6 months and currently treating with medium to high dose inhaled steroids for at least 8 weeks. Patients must be 12-80 years of age, non-smoker and BMI (Body Mass Index) of less than 40.
Compensation for participation may be provided to those who qualify. Please fill out the Volunteer Questionnaire or call 314-514-8509 for more details.
Study #7: Asthma Research Study for adults 18-75 years of age who have had asthma for at least one year and treat with a medium to high dose maintenance medication for at least 3 months
Brief description of study
This investigational research study is enrolling moderate to severe asthmatics. The study requires 6 visits over approximately 15 weeks. Study medication is an investigational inhaled corticosteroid (ICS) versus an investigational inhaled corticosteroid plus long-acting beta agonist (ICS/LABA). Pulmonary function test will be performed.
Compensation for participation may be provided for those who qualify. Please fill out the Volunteer Questionnaire or call 314-514-8509
